Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
暂无分享,去创建一个
[1] Michael J Cima,et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.
[2] A. Matzger,et al. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. , 2003, Journal of pharmaceutical sciences.
[3] Orn Almarsson,et al. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.
[4] A. Beatty,et al. A high-yielding supramolecular reaction. , 2002, Journal of the American Chemical Society.
[5] V. Lynch,et al. Recurrence of carboxylic acid-pyridine supramolecular synthon in the crystal structures of some pyrazinecarboxylic acids. , 2002, The Journal of organic chemistry.
[6] T. Steiner. The hydrogen bond in the solid state. , 2002, Angewandte Chemie.
[7] A. Beatty,et al. "Total Synthesis" Supramolecular Style: Design and Hydrogen-Bond-Directed Assembly of Ternary Supermolecules. , 2001, Angewandte Chemie.
[8] Y. Yamashita,et al. Crystal engineering using anilic acids and dipyridyl compounds through a new supramolecular synthon. , 2001, The Journal of organic chemistry.
[9] Y. Ito,et al. In situ X-ray observation of pedal-like conformational change and dimerization of trans-cinnamamide in cocrystals with phthalic acid. , 2001, Journal of the American Chemical Society.
[10] S. Byrn,et al. Chemical reactivity in solid-state pharmaceuticals: formulation implications. , 2001, Advanced drug delivery reviews.
[11] M. Zaworotko,et al. From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids. , 2001, Chemical reviews.
[12] Graham Smith,et al. Molecular Cocrystals of Aromatic Carboxylic Acids with Unsymmetrically Substituted Ureas. The Structures of Phenylurea and the 1 : 1 Adducts of Phenylurea with a Series of Nitro-Substituted Acids , 2000 .
[13] S. Ohba,et al. Compelled Orientational Control of the Solid-State Photodimerization of trans-Cinnamamides: Dicarboxylic Acid as a Non-covalent Linker , 2000 .
[14] J. White,et al. Molecular Cocrystals of Aromatic Carboxylic Acids with 1,1-Diethylurea: Synthesis and the Crystal Structures of a Series of Nitro-Substituted Analogues , 2000 .
[15] Bruno C. Hancock,et al. What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.
[16] B. Shekunov,et al. CRYSTALLIZATION PROCESSES IN PHARMACEUTICAL TECHNOLOGY AND DRUG DELIVERY DESIGN , 2000 .
[17] M. Caira,et al. Structure and solid-state chemistry of anhydrous and hydrated crystal forms of the trimethoprim-sulfamethoxypyridazine 1:1 molecular complex. , 2000, Journal of pharmaceutical sciences.
[18] S. Itai,et al. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. , 2000, International journal of pharmaceutics.
[19] D. Braga,et al. Crystal Engineering and Organometallic Architecture. , 1998, Chemical reviews.
[20] C. Rao,et al. Unexpected isomerization of maleic acid to fumaric acid on co-crystallization with 4,4′-bipyridine , 1998 .
[21] George Zografi,et al. Assessment of the physical stability of lyophilized MK-0591 by differential scanning calorimetry , 1996 .
[22] F. W. Fowler,et al. PREPARATION OF LAYERED DIACETYLENES AS A DEMONSTRATION OF STRATEGIES FOR SUPRAMOLECULAR SYNTHESIS , 1995 .
[23] M. C. Etter,et al. Urea-glutaric acid (2∶1) structural aggregates as building blocks for crystal engineering , 1995 .
[24] Gautam R. Desiraju,et al. Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .
[25] D. Tsiourvas,et al. THERMOTROPIC LIQUID CRYSTALS FORMED BY INTERMOLECULAR HYDROGEN BONDING INTERACTIONS , 1995 .
[26] Hiroyuki Nakazumi,et al. Near-infrared absorbing dyes , 1992 .
[27] M. C. Etter. Encoding and decoding hydrogen-bond patterns of organic compounds , 1990 .
[28] P. L. Gould,et al. Salt selection for basic drugs , 1986 .
[29] J. Finley,et al. Technological necessity of antioxidants in the food industry. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[30] T. Taga,et al. Structure redetermination and packing analysis of aspirin crystal. , 1985, Chemical & pharmaceutical bulletin.
[31] A. Hagler,et al. Conformational polymorphism. The influence of crystal structure on molecular conformation , 1978 .
[32] J. Haleblian,et al. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. , 1975, Journal of pharmaceutical sciences.
[33] J. Flippen,et al. (+)‐2‐(2‐Fluoro‐4‐biphenyl)propionic acid (flurbiprofen) , 1975 .
[34] L. Leiserowitz,et al. syn-planare Konformation der Oxalsure: Kristallstruktur des Oxalsure-Acetamid-Komplexes , 1972 .
[35] Gerhard M. J. Schmidt,et al. Photodimerization in the solid state , 1971 .
[36] C. Kennard,et al. Molecular Cocrystals of Carboxylic Acids. XXV The Utility of Urea in Structure Making with Carboxylic Acids and the Crystal Structures of a Set of Six Adducts with Aromatic Acids , 1997 .
[37] J. Kleinjans,et al. Butylated hydroxyanisole in perspective. , 1991, Chemico-biological interactions.
[38] F. Krahn,et al. Relations between several polymorphic forms and the dihydrate of carbamazepine. , 1987, Pharmaceutica acta Helvetiae.
[39] S. Byrn. Solid state chemistry of drugs , 1982 .
[40] L. Pauling. The Nature Of The Chemical Bond , 1939 .